致电 400-881-9290 或联系 在线客服
登录/ 注册
0 我的购物车
您当前的位置：
  1. 首页
  2. Signal path
  3. Others | 其他
  4. Biochemicals
ATRA-BA Hybrid
目录号 : KCM10134 CAS No. : 1037543-26-2 纯度 : ≥95%
Data Sheet 产品使用指南
ATRA-BA hybrid is a mutual prodrug form of all-trans retinoic acid (ATRA; ) and butyric acid (BA; ). ATRA-BA hybrid is cleaved to release ATRA and BA in isolated mouse plasma. It inhibits the growth of MDA-MB-231 breast and PC3 prostate cancer cells with GI values of 0.01 and 1.02 µM, respectively. ATRA-BA (20 µM) has 15-fold greater antiproliferative activity in PC3 cells compared to an equimolar concentration of ATRA and BA.
规格 价格 是否有货 数量
1mg
In-stock
5mg
In-stock
10mg
In-stock
加入购物车 大包装询价

Other Forms of Rapamycin:

KKL Med 的所有产品和服务仅用于科学研究，不能被用于人体，兽医，我们也不向个人提供产品和服务。
分子式
C31H40O4
分子量
476.7
CAS号
1037543-26-2
中文名称
ATRA-BA Hybrid
储存方式
Powder -20°C 3 years
  4°C 2 years
In solvent -80°C 6 months
  -20°C 1 month
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
重置 计算
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
重置 计算
联系我们
400-881-9290

technical-service@kklmed.com

terminal-order@kklmed.com

terminal-inspection@kklmed.com

dealer-order@kklmed.com

 10338 stony run ln，ste121，ashland，va，23005，USA
关注我们

Copyright © 2013-2022 KKL Med Inc. All Rights Reserved. 粤ICP备2022038512号-1
首页 分类 购物车 会员